Spica Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.16M

  • Investors
  • 5

Spica Therapeutics General Information

Description

Operator of a proprietary platform intended to target disease-relevant macrophage subsets for therapeutic purposes. The company's platform uses functional macrophage fingerprinting technology to identify and selectively modulate pathogenic macrophages, with a focus on oncology, fibroinflammatory, and autoimmune diseases, enabling patients to improve and address unmet medical needs through the development of therapies.

Contact Information

Website
www.spicatx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Uitbreidingstraat 66/3
  • 2600 Antwerp
  • Belgium
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Services
Vertical(s)
Corporate Office
  • Uitbreidingstraat 66/3
  • 2600 Antwerp
  • Belgium

Spica Therapeutics Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spica Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 27-Aug-2025 $1.16M Completed Startup
1. Seed Round 04-Jun-2025 Completed Startup
To view Spica Therapeutics’s complete valuation and funding history, request access »

Spica Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed Shares
To view Spica Therapeutics’s complete cap table history, request access »

Spica Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spica Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
VLAIO Limited Partner
Bioqube Ventures Venture Capital Minority
Flanders Future Techfund Venture Capital Minority
Qbic Fund Venture Capital Minority
VIB Not-For-Profit Venture Capital Minority
To view Spica Therapeutics’s complete investors history, request access »

Spica Therapeutics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Oncospear Hinnerup, Denmark 2021

Spica Therapeutics FAQs

  • When was Spica Therapeutics founded?

    Spica Therapeutics was founded in 2024.

  • Where is Spica Therapeutics headquartered?

    Spica Therapeutics is headquartered in Antwerp, Belgium.

  • What is the size of Spica Therapeutics?

    Spica Therapeutics has 6 total employees.

  • What industry is Spica Therapeutics in?

    Spica Therapeutics’s primary industry is Drug Discovery.

  • Is Spica Therapeutics a private or public company?

    Spica Therapeutics is a Private company.

  • What is Spica Therapeutics’s current revenue?

    The current revenue for Spica Therapeutics is .

  • How much funding has Spica Therapeutics raised over time?

    Spica Therapeutics has raised $11.3M.

  • Who are Spica Therapeutics’s investors?

    VLAIO, Bioqube Ventures, Flanders Future Techfund, Qbic Fund, and VIB have invested in Spica Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process